Cronos Group Inc (NASDAQ:CRON)
| 2.22 BATS BZX Real-Time Price As of 10:08am ET |  +0.045 / +2.07%Today’s Change | 1.64 Today|||52-Week Range 3.62 | -12.80% Year-to-Date |
Latest CRON News | Press Releases
| Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains? Sep 22 / Zacks.com - Paid Partner Content | Why These 3 Marijuana Stocks Rocketed Higher This Week Sep 14 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.17 |
| Today’s open | 2.17 |
| Day’s range | 2.15 - 2.22 |
| Volume | 49,296 |
| Average volume (3 months) | 2,229,422 |
| Market cap | $792.7M |
Data as of 10:08am ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +58.14% |
| Earnings growth (this year) | +67.22% |
| Earnings growth (next 5 years) | +11.54% |
| Revenue growth (last year) | +23.47% |
| P/E ratio | NM |
| Price/Sales | 10.41 |
| Price/Book | 0.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Abivax SA | 0.00 | 0.00% |
| ---- | ||
| USNAUSANA Health Science... | -0.41 | -0.69% |
| ---- |
Data as of 10:00am ET, 09/26/2023
Financials
| Next reporting date | November 14, 2023 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $91.9M |
| Annual profit (last year) | -$168.7M |
| Net profit margin | -183.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
